These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4927759)

  • 1. 3-O-methyldopa, a new precursor of dopamine.
    Bartholini G; Kuruma I; Pletscher A
    Nature; 1971 Apr; 230(5295):533-4. PubMed ID: 4927759
    [No Abstract]   [Full Text] [Related]  

  • 2. The metabolism of L-3-O-methyldopa, a precursor of dopa in man.
    Kuruma I; Bartholini G; Tissot R; Pletscher A
    Clin Pharmacol Ther; 1971; 12(4):678-82. PubMed ID: 5567811
    [No Abstract]   [Full Text] [Related]  

  • 3. The metabolic pathways of L-3-O-methyldopa.
    Bartholini G; Kuruma I; Pletscher A
    J Pharmacol Exp Ther; 1972 Oct; 183(1):65-72. PubMed ID: 5080035
    [No Abstract]   [Full Text] [Related]  

  • 4. Demethylation of L-3-methoxytyrosine in vivo.
    Bartholini G; Pletscher A
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 274(4):404-9. PubMed ID: 4263632
    [No Abstract]   [Full Text] [Related]  

  • 5. Stereotype hyperactive behaviour produced by dopamine in the absence of noradrenaline.
    Scheel-Krüger J; Randrup A
    Life Sci; 1967 Jul; 6(13):1389-98. PubMed ID: 6035768
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the accumulation of O-methylated dopamine and noradrenaline in the rat brain following various neuroleptics, thymoleptics and aceperone.
    Scheel-Krüger J
    Arch Int Pharmacodyn Ther; 1972 Feb; 195(2):372-8. PubMed ID: 5015941
    [No Abstract]   [Full Text] [Related]  

  • 7. [Catecholamine metabolism in the tissue of malignant and benign tumors of the sympathetic nervous system].
    Käser H; Türler K; Burri PH
    Schweiz Med Wochenschr; 1971 Apr; 101(13):484-7. PubMed ID: 5558918
    [No Abstract]   [Full Text] [Related]  

  • 8. [Urinary excretion of 3,4-dihydroxyphenyl-alanine, 3-O-methyldopa, dopamine and homovanillic acid in man. Effects of an inhibitor of decarboxylase of aromatic amino acids (Benserazide) (author's transl)].
    Geissbühler F; Widmer J
    J Clin Chem Clin Biochem; 1976 Nov; 14(11):543-7. PubMed ID: 1003116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fluorometric assay of catecholamines and related compounds: improvements and extensions to the hydroxyindole technique.
    Laverty R; Taylor KM
    Anal Biochem; 1968 Feb; 22(2):269-79. PubMed ID: 4868086
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in monoamines of rat brain during postnatal ontogeny.
    Agrawal HC; Glisson SN; Himwich WA
    Biochim Biophys Acta; 1966 Dec; 130(2):511-3. PubMed ID: 5972858
    [No Abstract]   [Full Text] [Related]  

  • 11. A new method for the determination of labeled DOPAMINE, norepinephrine and their metabolites in rat brain homogenate.
    Schweitzer JW; Friedhoff AJ
    Life Sci; 1969 Feb; 8(4):173-82. PubMed ID: 5777629
    [No Abstract]   [Full Text] [Related]  

  • 12. Brain dopamine and the amphetamine-reserpine interaction.
    Randrup A; Jonas W
    J Pharm Pharmacol; 1967 Jul; 19(7):483-4. PubMed ID: 4382645
    [No Abstract]   [Full Text] [Related]  

  • 13. A double column procedure for the simultaneous estimation of norepinephrine, normetanephrine, dopamine, 3-methoxytyramine and 5-hydroxytryptamine in brain tissue.
    Karasawa T; Furukawa K; Yoshida K; Shimizu M
    Jpn J Pharmacol; 1975 Dec; 25(6):727-36. PubMed ID: 1228255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-dopa-induced accumulation of 3-O-metyldopa in brain and heart.
    Kuruma I; Bartholini G; Pletscher A
    Eur J Pharmacol; 1970 May; 10(2):189-92. PubMed ID: 5446374
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolism of dihydroxyphenylalanine and tryptophan in pyridoxine-deficient rats.
    Sourkes TL; Missala K
    Ann N Y Acad Sci; 1969 Sep; 166(1):235-45. PubMed ID: 5262018
    [No Abstract]   [Full Text] [Related]  

  • 16. Catechol-O-methyltransferase. I. An enzymatic assay for cardiac norepinephrine.
    Nikodijevic B; Daly J; Creveling CR
    Biochem Pharmacol; 1969 Jul; 18(7):1577-84. PubMed ID: 5806102
    [No Abstract]   [Full Text] [Related]  

  • 17. Central and peripheral catecholamine turnover studied by means of 3H-DOPA and 3H-tyrosine.
    Persson T
    Acta Pharmacol Toxicol (Copenh); 1969; 27(6):397-409. PubMed ID: 5395728
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence that the hypotensive action of methyldopa is mediated by central actions of methylnoradrenaline.
    Henning M; Rubenson A
    J Pharm Pharmacol; 1971 Jun; 23(6):407-11. PubMed ID: 4397178
    [No Abstract]   [Full Text] [Related]  

  • 19. The metabolism of 14 C-labelled -methyldopa in normal and hypertensive human subjects.
    Au WY; Dring LG; Grahame-Smith DG; Isaac P; Williams RT
    Biochem J; 1972 Aug; 129(1):1-10. PubMed ID: 4646774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of DOPA in rat stomach following ingestion of cereals.
    Hoeldtke RD; Wurtman RJ
    Metabolism; 1974 Jan; 23(1):25-31. PubMed ID: 4808509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.